Meeting national tobacco challenges: recommendations for smoking cessation groups.
OBJECTIVE
To review the literature on model smoking cessation programs and provide an overview of the practice guidelines for intensive smoking cessation groups.


METHODS
Selected evidence-based literature and AHCPR/AHRQ clinical practice guidelines.


CONCLUSIONS
Smoking is the leading cause of preventable death in our global society and is expected to kill more people than any other disease within 20 years. Data support that most smokers want to quit and are more likely to succeed with a combination of behavioral and pharmacological support.


CONCLUSIONS
Smoking cessation must be a priority in the delivery of patient care. Intensive interventions are more effective than brief interventions and should be available for all smokers.
Andrews
J
J
Medical College of Georgia School of Nursing, Ga., USA. jandrews@msn.com
Heath
J
J
Harrell
L
L
Forbes
M
M
D001521:Behavior Therapy; D019317:Evidence-Based Medicine; D005731:Ganglionic Stimulants / Q000009:adverse effects / Q000627:therapeutic use; D019983:Guideline Adherence; D006291:Health Policy; D006801:Humans; D008389:Marketing of Health Services; D009538:Nicotine / Q000009:adverse effects / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D012657:Self-Help Groups; D012907:Smoking / Q000009:adverse effects; D016540:Smoking Cessation / Q000331:legislation & jurisprudence*
D005731:Ganglionic Stimulants; D009538:Nicotine